Opportunity Detail

Questions and Answers

Diabetic Supplies and Rebate Program
Document #:  JFSRFP121307803


Question:   How did ODJFS develop the RFP diabetes meter/test strip specifications? What patient care standards were utilized to determine the sample size and test time specifications? What constitutes partial credit as far as scoring evaluation is concerned?

Answer:   These specifications were established as baselines and determined using criteria from other state Medicaid programs that have implemented rebate programs for diabetic supplies. Applicants should include specifications for equipment and supplies to be used for this program. Applicants are expected to adhere to generally accepted patient care standards. Applicants must meet all specified criteria in the RFP and Technical Proposal Score Sheet. Where ODJFS may have identified some expected standard of performance, any offer of something below that standard could be awarded partial (or “partially meets”) credit. Offers of performance above that standard and which would be of use/value to the ODJFS program, may be awarded a higher score for these criteria.

Date: 7/20/2012

Inquiry: 26011


Question:   This question references Managed Care Enrollment Center Services “the Program”, the heading is entitled Article X Misc. Provisions, subsection F1, and is listed on an un-numbered page of Ohio RFP #JFSR1213078035. What is the referenced “Managed Care Enrollment Center Services (“the Program”)? This question is asked by Glenda Schwem, Manager of Contract Development (phone #510-749-6327) at Abbott Diabetes Care.

Answer:   The document was posted merely as a model, and that was what was appropriate for this RFP. The title of that program is not applicable and will be removed from the actual contract.

Date: 7/20/2012

Inquiry: 26010


Question:   This question references Ethics Laws, the heading is Article IX Contractor Certification of Compliance with Special Conditions on the Contract for Services, Subsection 3, and is listed on un-numbered pages at the back of the Ohio RFP #JFSR1213078035. Can the State please publish the Governor’s Executive Order 2011-03K pertaining to ethics for review by the Manufacturers? This question is asked by Glenda Schwem, Manager of Contract Development (phone #510-749-6327) at Abbott Diabetes Care.

Answer:   The Governor’s Executive Order 2011-03K can be viewed at: http://www.governor.ohio.gov/Portals/0/pdf/executiveOrders/EO2011-03.pdf

Date: 7/20/2012

Inquiry: 26009


Question:   This question references business associates requirements, the heading is entitled Article VIII Business Associate Requirements under HIPAA on the Contract for Services, and is listed on un-numbered pages at the back of the Ohio RFP #JFSR1213078035. Under what circumstances would the State provide Protected Health Information to the Manufacturer? There does not appear to be a need for the Manufacturer to receive any PHI. This question is asked by Glenda Schwem, Manager of Contract Development (phone #510-749-6327) at Abbott Diabetes Care.

Answer:   The State wanted all vendors to be aware of the potential language that may be required. If the State determines that no protected health information will be provided to the vendor then this article would be deleted out of the model contract.

Date: 7/20/2012

Inquiry: 26008


Question:   This question references suspension, the heading is entitled Article IV Suspension and Termination (b) on the Contract for Services, and is listed on un-numbered pages at the back of the Ohio RFP #JFSR1213078035. Please define what a suspended contract is (as compared to a terminated contract). This question is asked by Glenda Schwem, Manager of Contract Development (phone #510-749-6327) at Abbott Diabetes Care.

Answer:   Suspension occurs when the State instructs the vendor to temporarily stop work on all or a portion of the deliverables but will want the contract to continue once the issue for the suspension has been resolved. Termination of a contract would not allow the continuation of the contract past the termination date.

Date: 7/20/2012

Inquiry: 26007


Question:   This question references work for hire, the heading is entitled Attachment, Contract for Services, and is listed on un-numbered pages at the back of the Ohio RFP #JFSR1213078035. Many portions of this Model Contract appear to be applicable to a work-for-hire situation in which the State would pay the Manufacturer for a deliverable. Will the State re-draft the Model Contract to eliminate the work-for-hire concept, deliverables, and ownership of deliverables? The contract should reflect that if a Medicaid recipient purchases the Manufacturer’s diabetic blood glucose testing strip from a pharmacy, then the State is eligible to submit utilization data for a Rebate from the Manufacturer. The Manufacturer does not grant the intellectual property rights to the State. This question is asked by Glenda Schwem, Manager of Contract Development (phone #510-749-6327) at Abbott Diabetes Care.

Answer:   The State is willing to modify the Model Contract as appropriate to address ownership and work-for-hire concerns. The deliverables will be drafted in a manner that states what is being provided by the vendor.

Date: 7/20/2012

Inquiry: 26006


Question:   This question references samples of the diabetic testing supplies, the heading is entitled 4.4(E) Diabetic Supply Specifications, and is listed on page 18 of Ohio RFP #JFSR1213078035. Samples of each meter the Manufacturer proposes, with corresponding test strips, must be included in the proposal. Is one sample of each type of meter sufficient or does the State require a specified number of meters? Is one 50-count vial of test strips adequate or does each meter need a separate vial of test strips? Does the State need control solutions, lancing devices, and lancets to be included as samples? This question is asked by Glenda Schwem, Manager of Contract Development (phone #510-749-6327) at Abbott Diabetes Care.

Answer:   Manufacturers should provide one meter with a minimum of 10 test strips and control solution.

Date: 7/20/2012

Inquiry: 26004


Question:   This question references providing materials in the Somali language, the heading is entitled 4.4 (A) Marketing and Outreach, and is listed on page 16 of Ohio RFP #JFSR1213078035. The State is asking for “translated materials” in Somali. What type of document(s) does the State feel need to be in Somali? A blood glucose meter instruction booklet is an obvious choice for translation, but what other type of document(s) does the State feel need to be in Somali? Also, can the State be more specific about which Somali language is requested. The two common languages in Somalia are Arabic and three dialects/versions of Somali (Northern, Benadir, and Maay). This question is asked by Glenda Schwem, Manager of Contract Development (phone #510-749-6327) at Abbott Diabetes Care.

Answer:   All documents related to this RFP will need to be translated into Somali. According to the ODJFS Refugee Services Section, materials are generally translated in Somali Somali ("regular"). There is also a Bantu population in Ohio and they may speak Maay Maay so it would be helpful to these Medicaid consumers if translations in both languages could be provided.

Date: 7/20/2012

Inquiry: 26003


Question:   This question references rebate payment terms, the heading is entitled 4.3(A)(3) Establish a Preferred Product/Rebate Program, and is listed on page 15 of Ohio RFP #JFSR1213078035. The RFP states that rebates will be invoiced quarterly with payments due within 30 days after the invoice is issued. CMS uses a 38 day schedule for rebate payment. Will the State accept the CMS 38 day schedule for rebate payment? This question is asked by Glenda Schwem, Manager of Contract Development (phone #510-749-6327) at Abbott Diabetes Care.

Answer:   The CMS requirement allows 38 days after the postmark date of an invoice. ODJFS anticipates sending invoices electronically eliminating the need for extra time for the mail.

Date: 7/20/2012

Inquiry: 26002


Question:   This question references information delivery systems, the heading is entitled 4.4 (A) Specifications of Deliverables, and is listed on page 16 of Ohio RFP #JFSR1213078035. The RFP states that Manufacturers should provide information through multiple technology and information delivery systems. One listed item is Formulary Flash through Epocrates. Is the Epocrates software a mandatory requirement or is it an example? This question is asked by Glenda Schwem, Manager of Contract Development (phone #510-749-6327) at Abbott Diabetes Care.

Answer:   Epocrates is one example.

Date: 7/20/2012

Inquiry: 26001


Question:   This question references improvement in quality and health status of Ohio Medicaid consumers, the heading is entitled Section IV, introductory subsection and is listed on page 12 of Ohio RFP #JFSR1213078035. Please define “health status” and the criteria the State uses to determine “improvement in quality.” What type of documentation is the State requesting under this provision of the RFP? This question is asked by Glenda Schwem, Manager of Contract Development (phone #510-749-6327) at Abbott Diabetes Care.

Answer:   The documentation regarding improvement in quality and health status is in Section 4.1 Scope of Work. ODJFS will partner with the selected manufacturer(s) to identify improvement in health status and quality improvement criteria for Medicaid consumers.

Date: 7/20/2012

Inquiry: 26000


Question:   This question references the minimum requirement of processing at least 500,000 transactions per year for at least three years, the heading is entitled 3.2 (A)(3) Organizational Experience and Capabilities, and is listed on page 9 of Ohio RFP #JFSR1213078035. Please define what the State means by “transaction” as this can be interpreted several ways. Does this mean 500,000 orders each year or 500,000 line items total on orders each year? Is an order considered a separate transaction from a delivery? Does this mean 500,000 units of product? Is a rebate or a chargeback considered a transaction? This question is asked by Glenda Schwem, Manager of Contract Development (phone #510-749-6327) at Abbott Diabetes Care.

Answer:   This number was established as a baseline and defined as product distributed through the Applicant’s supply chain, such as test strips, meters, lancets and other supplies. RFP Applicants should submit specific information that is most relevant to any distribution method that they currently utilize for their products. This information should clearly articulate the Applicant’s distribution chain direct to consumer, distributor or any combination thereof and indicate the actual number of products being distributed by product type and description.

Date: 7/20/2012

Inquiry: 25999


Question:   This question references the minimum requirement of 2 years experience in maintaining an order processing and distribution network to serve at least 100,000 patients within Ohio, the heading is entitled 3.2 (A)(1) Organizational Experience and Capabilities, and is listed on page 9 of Ohio RFP #JFSR1213078035. May the Manufacturer simply explain in their proposal how their order processing system works and how products are distributed through various channels? Does the explanation need to be specific to Ohio? What type of documentation does the State wish to see? This question is asked by Glenda Schwem, Manager of Contract Development (phone #510-749-6327) at Abbott Diabetes Care.

Answer:   The explanation does not need to be specific to Ohio unless there are features unique to Ohio.

Date: 7/20/2012

Inquiry: 25998


Question:   This question references the minimum requirement of 3 years in providing rebates to health care plans, the heading is entitled 3.1(B) Mandatory Manufacturer Qualifications, and is listed on page 8 of Ohio RFP #JFSR1213078035. For Manufacturers that have ten years of experience in diabetic supplies, it would be onerous to list every single contract executed. It would be onerous to list every currently active contract. There could also be confidentiality issues involved so the Manufacturer will have to contact their customer and obtain permission to disclose the contractual relationship. May the Manufacturer simply state in their proposal that they meet the requirement of having the minimum three years experience in providing rebates and list a few of the contracts that have been active for more than 12 months? This question is asked by Glenda Schwem, Manager of Contract Development (phone #510-749-6327) at Abbott Diabetes Care.

Answer:   Yes.

Date: 7/20/2012

Inquiry: 25997


Question:   This question references the mandatory requirement of 10 years in manufacturing diabetic supplies, the heading is entitled 3.1(A) Mandatory Manufacturer Qualifications, and is listed on page 8 of Ohio RFP #JFSR1213078035. May the Manufacturer simply state in their proposal that they meet the requirement of having 10 years experience in manufacturing diabetic supplies? If not, please specify the exact type of documentation the State is requesting for this portion of the RFP. This question is asked by Glenda Schwem, Manager of Contract Development (phone #510-749-6327) at Abbott Diabetes Care.

Answer:   No, the manufacturer must provide a description of their experience in manufacturing diabetic supplies.

Date: 7/20/2012

Inquiry: 25996


Question:   This question references call center locations, the heading is entitled 4.4(F) Customer Support and Call Center Services, and is listed on page 20 of Ohio RFP #JFSR1213078035. This Section also refers to Section 8.23 which appears on page 37. Is it an automatic elimination from the RFP if a Call Center is located outside of the USA? Or is it an item that may not disqualify a Manufacturer but may not receive top scores? This question is asked by Glenda Schwem, Manager of Contract Development (phone #510-749-6327) at Abbott Diabetes Care.

Answer:   Page 20 of the RFP states that the customer support and call center services must be located within the United States; therefore, a vendor would be eliminated if the call center is not located within the United States.

Date: 7/20/2012

Inquiry: 25995


Question:   This question references the Implementation Date of any awarded contract, the heading is entitled 2.1 Anticipated Procurement Timetable, and is listed on page 5 of Ohio RFP #JFSR1213078035. The table states that any awarded contract will be implemented November 1, 2012. This appears to be different than stated later in the RFP. [4.3 Objectives and Administrative Structures, Milestones subsection, page 13] The Milestones states the PDSRB begins Sept 15, 2012 and that Ohio will require prior authorization for non-preferred products on October 1, 2012. What will be the start date of the awarded contract(s)? What date does the State expect Manufacturers to use for the State’s rebate eligibility? Will the State allow Medicaid recipients to use grandfathered manufacturer’s product (a Manufacturer that is not selected as a Preferred Manufacturer)? This question is asked by Glenda Schwem, Manager of Contract Development (phone #510-749-6327) at Abbott Diabetes Care.

Answer:   The anticipated start date of the contract is November 1. The contract will specify the actual start date. ODJFS will allow a transition period of approximately one month.

Date: 7/20/2012

Inquiry: 25994


Question:   This question references Problem Resolution Systems, the heading is entitled 1.4 Objectives of the Project, subsection 5, and is listed on page 4 of Ohio RFP #JFSR1213078035. Please specify in detail what the State defines as an adequate “problem resolution system.” Does a customer support center that answers questions about the diabetic testing supplies, provides diabetes education, provides any product replacement needed, and keeps records of the same meet the State’s expectations of a “problem resolution system?” This question is asked by Glenda Schwem, Manager of Contract Development (phone #510-749-6327) at Abbott Diabetes Care.

Answer:   Applicants should be able to demonstrate the ability to manage problems. This is addressed in Section 4.4.F Customer Support and Call Center Services.

Date: 7/20/2012

Inquiry: 25993


Question:   This question references Problem Resolution Systems, the heading is entitled 1.4 Objectives of the Project, subsection 5, and is listed on page 4 of Ohio RFP #JFSR1213078035. Please specify in detail what the State defines as an adequate “problem resolution system.” Does a customer support center that answers questions about the diabetic testing supplies, provides diabetes education, provides any product replacement needed, and keeps records of the same meet the State’s expectations of a “problem resolution system?” This question is asked by Glenda Schwem, Manager of Contract Development (phone #510-749-6327) at Abbott Diabetes Care.

Answer:   Applicants should be able to demonstrate the ability to manage problems. This is addressed in Section 4.4.F Customer Support and Call Center Services.

Date: 7/20/2012

Inquiry: 25992


Question:   This question references Problem Resolution Systems, the heading is entitled 1.4 Objectives of the Project, subsection 5, and is listed on page 4 of Ohio RFP #JFSR1213078035. Please specify in detail what the State defines as an adequate “problem resolution system.” Does a customer support center that answers questions about the diabetic testing supplies, provides diabetes education, provides any product replacement needed, and keeps records of the same meet the State’s expectations of a “problem resolution system?” This question is asked by Glenda Schwem, Manager of Contract Development (phone #510-749-6327) at Abbott Diabetes Care.

Answer:   Applicants should be able to demonstrate the ability to manage problems. This is addressed in Section 4.4.F Customer Support and Call Center Services.

Date: 7/20/2012

Inquiry: 25991


Question:   This question references Problem Resolution Systems, the heading is entitled 1.4 Objectives of the Project, subsection 5, and is listed on page 4 of Ohio RFP #JFSR1213078035. Please specify in detail what the State defines as an adequate “problem resolution system.” Does a customer support center that answers questions about the diabetic testing supplies, provides diabetes education, provides any product replacement needed, and keeps records of the same meet the State’s expectations of a “problem resolution system?” This question is asked by Glenda Schwem, Manager of Contract Development (phone #510-749-6327) at Abbott Diabetes Care.

Answer:   Applicants should be able to demonstrate the ability to manage problems. This is addressed in Section 4.4.F Customer Support and Call Center Services.

Date: 7/20/2012

Inquiry: 25990


Question:   (page 9 section 3.2.A.3) In regards to our experience processing at least 500,000 transactions per year from order to produt delivery. This question appears to be aimed at manufacturers that ship directly to the end consumer. Since we use retailers and DMEs to distribute our products we dont come close to filling 500k transactions per year. We have over 2 million consumers using ACCU-CHEK products but we do not process transactions for these customers. Most if not all Manufacturers of blood glucose testing supplies do not deliver direct to the consumer. Can you please explain the order to product delievery you are looking for?

Answer:   This number was established as a baseline. RFP Applicants should submit specific information that is most relevant to any distribution method that they currently utilize for their products. This information should clearly articulate the Applicant’s distribution chain direct to consumer, distributor or any combination thereof.

Date: 7/20/2012

Inquiry: 25982


Question:   (page 16 section A) How will ODJFS comunicate to providers the Medicaid beneficiaries the preferred brand(s) in the program? For example, mailing? email communication?

Answer:   ODJFS will communicate information through the ODJFS website, provider communications and professional associations.

Date: 7/20/2012

Inquiry: 25981


Question:   (page 17 section D) How does the manufacturer reimburse the state for rebate payments, via check or EFT wire?

Answer:   ODJFS can accept payments through either process.

Date: 7/20/2012

Inquiry: 25980


Question:  

Answer:   (page 17 section D) How does the manufacturer reimburse the state for rebate payments, via check or EFT wire? Answer: ODJFS can accept payments through either process

Date: 7/19/2012

Inquiry: 25979


Question:   (page 17 section D) What data is included in the states quarterly invoice? Rx level detail? Sent electronically in an Excel format?

Answer:   The data elements identified in Section 4.4.D. will be provided in the aggregate quarterly, similar to invoices for Medicaid drug rebates specified by CMS. The invoice will be in PDF format. In the event of rebate invoice disputes, ODJFS will provide claim-level detail in a format to be agreed upon by ODJFS and the manufacturer.

Date: 7/19/2012

Inquiry: 25979


Question:   (Attachment A.3.A) Does the Vendor Ohio Administrative Knowledge Systems (OAKS) apply to us and if yes, how? Please explain

Answer:   It is a requirement for all companies for which the State of Ohio does business.

Date: 7/19/2012

Inquiry: 25978


Question:   (page 16 and section A) In regards to the technology and information delievery systems is it required to use formulary flash through Epocrates?

Answer:   This section gives examples of the marketing and outreach that ODJFS will require of the manufacturer. ODJFS will work with the selected manufacturer(s) to determine the exact marketing strategies.

Date: 7/19/2012

Inquiry: 25977


Question:   (page 16 section A) In regards to the educational materials. Is it a requirement of offer educational material in Somali? If so, can you provide estimates of the size of the Somali speaking Medicaid populations?

Answer:   Yes, materials must be provided in English, Spanish and Somali. We cannot provide data at this time on the size of the Somali-speaking Medicaid population, but according to ODJFS' Refugee Services Section, 4335 Somali refugees have been resettled in Ohio in the last seven years, but this does not include Somali immigrants or Somali refugees who moved to Ohio from other states. As refugees, they are generally eligible for Medicaid for their first seven years in the U.S. If they become U.S. citizens or Lawful Permanent residents with 40 qualifying work quarters, they may receive Medicaid beyond their seven year limit.

Date: 7/19/2012

Inquiry: 25976


Question:  

Answer:   (page 20 section F) In regards to Customer Service, Does ODJFS expect the Manufacturer to provide a dedicated customer line for Ohio Medicaid beneficiaries? Answer: No.

Date: 7/19/2012

Inquiry: 25975


Question:   (page 16 section A) in regards to Marketing and Outreach, will ODJFS be willing to provide a list of their pharmacy providers including chain drug and independent pharmacies?

Answer:   Yes.

Date: 7/19/2012

Inquiry: 25974


Question:   (Attachment D) Will you be sending over Attachment D in an excel file for us to save to a CD?

Answer:   All documents posted to ODJFS’ web page must be in PDF format. Please print Attachment D and fill in.

Date: 7/19/2012

Inquiry: 25973


Question:   (page 23 section G) Availability through retail and mail order pharmacies, what type of mail order pharmacies are you referring to? National DMEs? Can you give us some examples?

Answer:   The manufacturer’s products should be available through all pharmacies participating with Ohio Medicaid that would like to provide diabetic supplies. The manufacturer must not require a limited distribution network.

Date: 7/19/2012

Inquiry: 25972


Question:   (page 8 sec 3.1.A) Please elaborate on 10 years experience, what type of experience are you looking for regarding activities?

Answer:   As stated in Section 3.1, manufacturers must have a minimum of 10 years experience in manufacturing or distributing diabetic supplies for the retail pharmacy and/or hospital market. Other required qualifications are described in Section 3.2.

Date: 7/19/2012

Inquiry: 25971


Question:   (page 5 and page 13 timeline) The timelines identified on these 2 pages are different, which one is correct?

Answer:   The timeline in Section 2.1 is correct, anticipating a start date of November 1.

Date: 7/19/2012

Inquiry: 25970


Question:   (page 3 Fiscal Soundness) Please explain the reason for the performance bond of 5%.

Answer:   The selected manufacturer must be in compliance with IRS and state and local regulations, and with no currently outstanding audit findings by these regulatory authorities as related to these processes. The provision of a 5% performance bond would indicate the vendor’s fiscal soundness.

Date: 7/19/2012

Inquiry: 25969


Question:   (page 18 section E.1.A.3) Is it a requirement to have at least one meter with a result time in less than 5 seconds?

Answer:   Yes, it is a requirement.

Date: 7/19/2012

Inquiry: 25968


Question:   (page 18 section E.1.A.2) It the .3 microliter sample of blood mandatory or just preferred, please elaborate?

Answer:   The .3 microliter sample of blood is mandatory.

Date: 7/19/2012

Inquiry: 25967


Question:   (page 31, section 8.2) Can we have an opportunity to request to present our product portfolio to the P&T committee? If yes, what is the process and timeline?

Answer:   ODJFS anticipates that the contract award notification letter(s) will be sent to the selected manufacturer(s) by August 16, 2012. The P&T Committee meets in mid-October and the selection process will have already been completed. If the state deems it necessary, clinical presentations will be scheduled with state staff.

Date: 7/19/2012

Inquiry: 25966


Question:   Clarification question regarding Section 3.1, Mandatory Manufacturer Qualifications on Page 8. Regarding Part C - the financial audit requirement. Would a compiled financial statement/compilation report be satisfactory?

Answer:   No, ODJFS wants an independent audit of the current or previous year's financials.

Date: 7/19/2012

Inquiry: 25939


Question:   Clarification question regarding Section 5.2 (C), Cost Proposal on Page 25 and Section 4.4 (D), Rebates on Page 17. This section states that once the rebate contracts are in place, reimbursement will change to the formula WAC + 7%. Manufacturers will then be invoiced for a rebate that is reimbursement (WAC + 7%) minus the GNUP. Three questions: 1) Is a dispensing fee also included in this reimbursement, and if so, is the dispensing fee going to be factored/included in the rebate? 2) Meters are expected to be GNUP = $0.00. In some business relationships with pharmacies, we have provided free meters to the pharmacies. Usually when this occurs, the pharmacy can not submit the meter for reimbursement. Would ODJFS reimburse a pharmacy for a meter the pharmacy received for free? If so, would a rebate be expected from the manufacturer? Or is the expectation that pharmacies will always pay for meters? 3) The RFP states the reimbursement rate of WAC + 7%. What expectations are there as far as whether this reimbursement rate might be increased/adjusted in the future? Accordingly, what notice would we receive as manufacturers?

Answer:   No dispensing fee is paid for diabetic supplies. 2)Medicaid providers are not permitted to bill for free goods, so no payment will be made or rebate invoiced. 3)The pricing methodology is in Ohio Administrative Code and any changes to the methodology would fall under the rulemaking process. Any changes will be communicated to the selected manufacturer(s).

Date: 7/19/2012

Inquiry: 25936


Question:   Clarification question in regards to Section 4.4D, Rebates on Page 17. In regards to GNUP for diabetic test strips - the document states that test strips and lancets must have a consistent GNUP across package sizes and product types (e.g. all glucose test strips). To clarify, does this mean that two different test strip products must have the same GNUP for a bottle of 50 strips, even if they use different meter platforms and test strip chemistry?

Answer:   Correct, all blood glucose test strips must have the same GNUP. If the meter uses strips to test for blood ketones or other functions, the GNUP for those strips may be different.

Date: 7/19/2012

Inquiry: 25932


Question:   Question regarding Section 4.2 (Number of Participants) on page 14 of the RFP document. Could you please share what number or percentage of the population of 250,000 are diabetic? How many of this group are currently using diabetic supplies?

Answer:   Between November 1, 2011, and April 30, 2012, 8,635 unique patients received blood glucose test strips through Ohio Medicaid. Data on the percentage of population with a diagnosis of diabetes is not available.

Date: 7/19/2012

Inquiry: 25930


Question:   Page 36 of 37. Section 8.18 Mandatory Disclosures of Governmental Investigations. Question: What is meant by "adverse regulatory or adverse administrative governmental action?" These are very broad statements. Can manufacturers apply the standards under the Federal Awardee Performance Integrity & Information system, which defines these terms and applies a 5-year time frame.

Answer:   A company may be adversely affected by judgments, settlements, unanticipated costs or other effects of legal and administrative proceedings now pending or that may be instituted in the future, or from investigations by regulatory bodies or administrative agencies. An adverse outcome might result in administrative or civil proceedings, sanctions and the payment of fines and penalties.

Date: 7/19/2012

Inquiry: 25925


back

Inquiry period ended:  7/16/2012 8:00:00 AM